miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1

Yi Fang1,2,3, Ting Xie1, Ning Xue1

  • 1Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

MicroRNA-382 (miR-382) exacerbates kidney fibrosis by targeting heat shock protein 60 (HSPD1), leading to redox imbalance. Inhibiting miR-382 may offer a therapeutic strategy for chronic kidney disease (CKD).

Area of Science:

  • Nephrology
  • Molecular Biology
  • Oxidative Stress Research

Background:

  • Redox imbalance is a key factor in chronic kidney disease (CKD) progression.
  • MicroRNA-382 (miR-382) is implicated in epithelial polarity loss but its role in renal fibrosis is unclear.

Purpose of the Study:

  • To investigate the role of miR-382 in the development of renal tubulointerstitial fibrosis.
  • To elucidate the underlying molecular mechanisms involving redox imbalance and potential targets.

Main Methods:

  • Unilateral ureteral obstruction (UUO) model in mice to induce kidney fibrosis.
  • In vitro studies using kidney epithelial cells and TGF-β1 stimulation.
  • Analysis of miR-382, heat shock protein 60 (HSPD1), 3-nitrotyrosine (3-NT), and thioredoxin (Trx) expression.
  • Treatment with anti-miR-382 and siRNA targeting HSPD1.

Main Results:

  • miR-382 and 3-NT were upregulated, while HSPD1 and Trx were downregulated in UUO kidneys and in patients with IgA nephropathy and fibrosis.
  • Anti-miR-382 treatment attenuated fibrosis, reversed molecular changes, and reduced oxidative stress.
  • HSPD1 overexpression restored Trx and E-cadherin, while HSPD1 suppression promoted oxidative stress.

Conclusions:

  • miR-382 targets HSPD1, contributing to redox imbalance and promoting renal tubulointerstitial fibrosis.
  • Targeting miR-382 presents a potential therapeutic approach for kidney fibrosis.
  • The miR-382/HSPD1 axis is a novel mechanism in CKD pathogenesis.